• Citer

Final results of a meta-analysis testing HER2 and topoisomerase IIα genes as predictors of incremental benefit from anthracyclines in breast cancer

par Di Leo, Angelo ;Desmedt, Christine ;Bartlett, John;Ejlertsen, Bent;Pritchard, Kathleen;Poole, CJ;Larsimont, Denis ;Tanner, M;Piette, F;Buyse, Marc
Référence ASCO Annual Meeting(June 4-8, 2010: Chicago, Il, USA), Journal of Clinical Oncology, 2010 ASCO Annual Meeting Abstracts, Vol. Vol 28, No 15_suppl
Publication Publié, 2010-05

Abstract de conférence

• Détails
• Contenu

Titre:	Final results of a meta-analysis testing HER2 and topoisomerase IIα genes as predictors of incremental benefit from anthracyclines in breast cancer
Auteur:	Di Leo, Angelo; Desmedt, Christine; Bartlett, John; Ejlertsen, Bent; Pritchard, Kathleen; Poole, CJ; Larsimont, Denis; Tanner, M; Piette, F; Buyse, Marc
Informations sur la publication:	ASCO Annual Meeting(June 4-8, 2010: Chicago, Il, USA), Journal of Clinical Oncology, 2010 ASCO Annual Meeting Abstracts, Vol. Vol 28, No 15_suppl
Statut de publication:	Publié, 2010-05
Sujet CREF:	Sciences bio-médicales et agricoles
	Médecine pathologie humaine
	Cancérologie
Langue:	Anglais